User profiles for Tadaki Suzuki
 | Tadaki SuzukiNational Institute of Infectious Diseases Verified email at niid.go.jp Cited by 13619 |
Mucosal IgA responses in influenza virus infections; thoughts for vaccine design
E van Riet, A Ainai, T Suzuki, H Hasegawa - Vaccine, 2012 - Elsevier
The current challenge in influenza vaccine design is to induce long-lasting protection not only
against the vaccine strain, but also against drifted (point mutations in the surface antigens …
against the vaccine strain, but also against drifted (point mutations in the surface antigens …
[HTML][HTML] SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …
escape from protection by vaccines and therapeutic antibodies. A key test for potential …
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2;
SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with …
SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with …
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
The spike aspartic acid–614 to glycine (D614G) substitution is prevalent in global severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, but its effects on viral …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, but its effects on viral …
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
…, N Ohmagari, M Kuroda, T Suzuki… - Proceedings of the …, 2020 - National Acad Sciences
A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently …
which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently …
[HTML][HTML] Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5
Subvariants | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram …
Subvariants | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram …
The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan
Background. Severe fever with thrombocytopenia syndrome (SFTS) is caused by SFTS
virus (SFTSV), a novel bunyavirus reported to be endemic in central and northeastern China. …
virus (SFTSV), a novel bunyavirus reported to be endemic in central and northeastern China. …
[HTML][HTML] Efficacy of antiviral agents against omicron subvariants BQ. 1.1 and XBB
…, S Fukushi, S Watanabe, T Suzuki… - … England Journal of …, 2023 - Mass Medical Soc
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
[HTML][HTML] COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
…, R Scendoni, S Mukhopadhyay, T Suzuki… - Clinical Microbiology …, 2022 - Elsevier
Background Many postmortem studies address the cardiovascular effects of COVID-19 and
provide valuable information, but are limited by their small sample size. Objectives The aim …
provide valuable information, but are limited by their small sample size. Objectives The aim …
[HTML][HTML] Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2
…, MS Diamond, H Hasegawa, H Mitsuya, T Suzuki… - Nature, 2022 - nature.com
The recent emergence of SARS-CoV-2 Omicron (B.1.1.529 lineage) variants possessing
numerous mutations has raised concerns of decreased effectiveness of current vaccines, …
numerous mutations has raised concerns of decreased effectiveness of current vaccines, …